China’s Ministry of Commerce said it will lift export restrictions on Illumina sequencers effective November 10, reopening a major market after months of trade curbs. Illumina confirmed the reversal and said it will work with Chinese authorities as the company remains on certain trade watchlists. The move restores a key commercial channel for sequencing suppliers and could ease supply constraints for genomic labs in China. Companies with China exposure should reassess market forecasts and regulatory compliance plans now that instruments can again be imported.